Related Experiment Video
Updated: Jun 6, 2025

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Up-Regulated Expression of Thioredoxin-Interacting Protein (TXNIP) in Mesenchymal Stem Cells Associated with Severe
Ying-Hsuan Peng1,2, Chang-Wei Li3, Kang-Hsi Wu1,4
1Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
Insights
Bone marrow mesenchymal stem cells (MSCs) in children with severe aplastic anemia (SAA) show increased senescence and altered gene expression. TXNIP up-regulation and IGFBP-1 increase may contribute to SAA pathogenesis.
Area of Science:
- Hematology
- Stem Cell Biology
- Molecular Medicine
Background:
- Severe aplastic anemia (SAA) pathogenesis in children is not fully understood.
- Bone marrow microenvironment insufficiency, involving mesenchymal stem cells (MSCs), is a potential factor in SAA-related hematopoietic impairment.
Purpose of the Study:
- To investigate the characteristics of bone marrow MSCs in children with SAA.
- To identify molecular mechanisms contributing to SAA pathogenesis.
Main Methods:
- Comparison of bone marrow MSCs from five children with SAA and five healthy controls.
- Assessment of senescence-associated β-galactosidase activity.
- RNA sequencing analysis to identify differential gene expression.
- Quantitative PCR (qPCR) validation.
- Measurement of IGF-1 and IGFBP-1 expression levels.
Main Results:
- SAA MSCs exhibited higher senescence-associated β-galactosidase activity.
- RNA sequencing revealed distinct transcriptomes in SAA MSCs, with up-regulated TXNIP.
- qPCR validated TXNIP up-regulation.
- SAA MSCs showed significantly increased IGFBP-1 expression, despite variable IGF-1 levels.
Conclusions:
- Increased TXNIP expression in SAA MSCs may impair their proliferative potential and contribute to SAA pathogenesis.
- A potential pathogenic mechanism involves a compensated increase in MSC IGF-1 to down-regulate TXNIP, which is counteracted by elevated IGFBP-1 expression in SAA.
Abstract:
The pathogenic mechanisms of severe aplastic anemia (SAA) in children are not completely elucidated. The insufficiency of the bone marrow microenvironment, in which mesenchymal stem cells (MSCs) are an important element, can be a potential factor associated with hematopoietic impairment in SAA. In the present study, we compared bone marrow MSCs from five children with SAA and five controls. We found a higher intensity of senescence-associated β-galactosidase activity in SAA MSCs, indicating the increased senescence in these cells. Further RNA sequencing analysis identified a distinctive profile of transcriptomes in SAA MSCs. After conducting a survey of the differentially expressed genes, we found that the up-regulated expression of TXNIP may compromise the proliferative potential of MSCs and probably relate to the pathogenesis of SAA. These results were validated by qPCR. To explore the molecular mechanism involving aberrant TXNIP regulation in SAA MSCs, the expression levels of IGF-1 and IGFBP-1 were measured. A significant increase in IGFBP-1 expression was noted in SAA MSCs despite the wide range of IGF-1 expressions. Accordingly, we postulated a novel pathogenic mechanism of SAA: a compensated increase in the expression of IGF-1 in MSCs to down-regulate TXNIP expression in the face of SAA, which is offset by the up-regulated expression of IGFBP-1.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells
iPS Cell Differentiation

